Zhang, G.,
Zhu, Y.,
Ling, Y.,
Chen, P.,
Dai, J.,
Wang, Ch.,
Xu, Sh.,
Shumadalova, A.,
Shi, H. (2022) ) occlusion is rare but associated with high morbidity and mortality
rates. However, the optimal treatment
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) diseases with a high
rate of mortality in patients with SSDs. Neuropeptide Y receptor Y5 (NPY5R) is known
Xu, Dongxiao,
Zheng, Bingjie,
Wu, Qiaowei,
Yao, Jinbiao,
Ilyasova, Tatiana,
Beilerli, Aferinc,
Shi, Huaizhang (2022) (51.6%), fair in 4 patients (6.0%), and poor in 1 patient (1.5%); the overall
rate of favorable